Breast cancer risk in transgender people receiving hormone treatment: Nationwide cohort study in the Netherlands

BMJ May 21, 2019

de Blok CJM, et al. - Incidence and features of breast cancer in transgender people in the Netherlands vs the general Dutch population was assessed by the authors in 1,229 adult trans men (female sex assigned at birth, male gender identity) and 2,260 adult trans women (male sex assigned at birth, female gender identity) receiving gender affirming hormone treatment. A lower risk of breast cancer in trans men vs cisgender women and a higher risk in trans women vs cisgender men was seen in this study. Breast cancer risk increased during a comparatively brief duration of hormone treatment in trans women with a a more female pattern emerging. For transgender people using hormone treatment, breast cancer screening guidelines for cisgender people were adequate.

Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay